Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
- Status
- RECRUITING
- Phase
- N/A
Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
- Status
- RECRUITING
- Phase
- N/A
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
- Status
- NOT_YET_RECRUITING
- Phase
- NA
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study to Learn More About Tukysa Once it is Out in the Korean Market
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
- Status
- RECRUITING
- Phase
- NA
Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA